abstract |
There are provided novel compounds of formula I ##STR1## wherein D, R 1 , R 2 , R 3 , X and p are as defined in the specification together with processes for their preparation, compositions containing them and their use in therapy. n Compounds of formula I are expected to be useful inter alia in the treatment of neurodegenerative disorders. |